Further analyses showed that low expression of Skp2 led to better survival in LGG (n = 510, p < 0.0001, Fig. 1d) but not in GBM (n = 151, p = 0.1616, Fig. 1e). The gene discussed is SKP2; the disease is glioblastoma.